How does co-investment access to pre-qualified, regulation-navigated HealthTech / MedTech / BioTech assets sound? Interesting, to say the least. Thanks to our embedded execution infrastructure, you’re getting a risk-free option for your capital.

This means you enter later, cleaner, and with higher exit confidence than if you source independently.

In the European HealthTech regulatory maze, there’s no need to wander alone. Our team handles approvals, clinical evidence, and commercial adoption.

We do the hard part so your private capital can work smarter, with structured protection and multiple realistic exit scenarios.

If your goal is to turn your pure research into an investable venture, we should talk about licensing options. We provide the regulatory, clinical, and commercial infrastructure that academic spinoffs typically lack.

By closing the gap between scientific discovery and market-ready, fundable assets, we bring you closer to results that generate lasting impact and institutional returns.

As intriguing as building an innovation infrastructure from scratch might seem, it isn’t necessary. We can provide you access to qualified, deployment-ready ventures that fit your strategic priorities.

Plus, you can choose the collaboration model: through partnership, licensing, or corporate venture (or a different alternative we may bring to the table).

We do our best to strengthen Europe’s health innovation ecosystem by converting publicly funded research into regulated, clinically validated ventures.

In accordance with EU frameworks, we generate measurable health and economic impact, leading capital towards deployment rather than discovery alone.